Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Sohn

Showing results (201-210 of 253) with videos related to

Pageof 26
Sort By:
European Radiology|December 14, 2020
Evaluation of the FUSION-X-US-II prototype to combine automated breast ultrasound and tomosynthesisBenedikt Schäfgen, Marija Juskic, Marcus Radicke, et al.
Carcinogenesis|April 21, 2017
The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studiesRongxi Yang, Sarah Stöcker, Sarah Schott, et al.
Breast Cancer Research and Treatment|April 15, 2014
Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significanceHarald Martin Surowy, Christian Sutter, Max Mittnacht, et al.
BMC Cancer|July 13, 2014
Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patientsMarkus Wallwiener, Sabine Riethdorf, Andreas Daniel Hartkopf, et al.
Clinical Breast Cancer|May 19, 2007
Doxorubicin/pemetrexed followed by docetaxel versus doxorubicin/ cyclophosphamide followed by docetaxel as neoadjuvant treatment for early-stage breast cancer: a randomized phase II trialAndreas Schneeweiss, Ilka Lauschner, Amparo Ruiz, et al.
JMIR Cancer|August 9, 2017
Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer PatientsAndreas D Hartkopf, Joachim Graf, Elisabeth Simoes, et al.
Radiation Oncology (London, England)|June 4, 2020
Fatigue following radiotherapy of low-risk early breast cancer - a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)Tobias Forster, Cornelia Jäkel, Sati Akbaba, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 4, 2021
Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trialTobias Forster, Adriane Hommertgen, Matthias Felix Häfner, et al.
International Journal of Cancer|December 22, 2015
Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancerCike Peng, Markus Wallwiener, Anja Rudolph, et al.
International Journal of Radiation Oncology, Biology, Physics|December 15, 2020
Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial)Juliane Hörner-Rieber, Tobias Forster, Adriane Hommertgen, et al.
Pageof 26

Showing results (201-210 of 253) with videos related to

Sort By:
Pageof 26
European Radiology|December 14, 2020
Evaluation of the FUSION-X-US-II prototype to combine automated breast ultrasound and tomosynthesisBenedikt Schäfgen, Marija Juskic, Marcus Radicke, et al.
Carcinogenesis|April 21, 2017
The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studiesRongxi Yang, Sarah Stöcker, Sarah Schott, et al.
Breast Cancer Research and Treatment|April 15, 2014
Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significanceHarald Martin Surowy, Christian Sutter, Max Mittnacht, et al.
BMC Cancer|July 13, 2014
Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patientsMarkus Wallwiener, Sabine Riethdorf, Andreas Daniel Hartkopf, et al.
Clinical Breast Cancer|May 19, 2007
Doxorubicin/pemetrexed followed by docetaxel versus doxorubicin/ cyclophosphamide followed by docetaxel as neoadjuvant treatment for early-stage breast cancer: a randomized phase II trialAndreas Schneeweiss, Ilka Lauschner, Amparo Ruiz, et al.
JMIR Cancer|August 9, 2017
Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer PatientsAndreas D Hartkopf, Joachim Graf, Elisabeth Simoes, et al.
Radiation Oncology (London, England)|June 4, 2020
Fatigue following radiotherapy of low-risk early breast cancer - a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)Tobias Forster, Cornelia Jäkel, Sati Akbaba, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 4, 2021
Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trialTobias Forster, Adriane Hommertgen, Matthias Felix Häfner, et al.
International Journal of Cancer|December 22, 2015
Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancerCike Peng, Markus Wallwiener, Anja Rudolph, et al.
International Journal of Radiation Oncology, Biology, Physics|December 15, 2020
Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial)Juliane Hörner-Rieber, Tobias Forster, Adriane Hommertgen, et al.
Pageof 26